Riverland Trombopag Eltrombopag

Revolade (eltrombopag) increases the production of platelets (blood clotting cells) in the body. Eltrombopag reduces the risk of bleeding by increasing platelets in the blood. Revolade is used to prevent bleeding events in adults and children 1 year and older with chronic immune thrombocytopenic purpura (ITP). Revolade is also used with other medicines to treat severe aplastic anemia in adults and children at least 2 years of age.